maiden profit achieved in FY14. Expected cash burn in 2015 which you can see is reducing and with milestone payments to be honoured, bno is in a positive but still speculative position imho. once the first major contracts are signed it will be a feather in the cap for this stock
wolf
Ann: BNC105 Enhances Efficacy of Immuno-Oncology Therapies, page-13
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)